U.S. Defense Secretary Pete Hegseth has ordered the termination of several information technology services contracts valued at $5.1 billion, including companies such as Accenture, Booz Allen Hamilton and Deloitte, according to a Pentagon memo.
The contracts “represent non-essential spending on third party consultants” for services Pentagon employees can perform, Hegseth said in the memo released late on Thursday.
“These terminations represent $5.1 billion in wasteful spending,” Hegseth said, adding that their termination would result in “nearly $4 billion in estimated savings.”
During morning trading in New York shares of Booz Allen Hamilton were down 2.4% to $106.30 and Accenture shares were down 2% to $279.52.
Representatives for Accenture, Deloitte (DLTE.UL) and Booz Allen Hamiltondid not immediately respond to requests for comment.
The contracts appeared to be wide-ranging cuts to consulting services for the Navy, the Air Force, the Defense Advanced Research Projects Agency (DARPA) and the Defense Health Agency
In a video posted on X, Hegseth said the contracts were for “ancillary things like consulting and other non-essential services.” He said the services would be brought in-house.
In the memo Hegseth said he was directing the Pentagon’s chief information officer to work over the next 30 days with tech billionaire Elon Musk’s Department of Government Efficiency to prepare a plan to cut and in-source the Defense Department’s information technology consulting and management services.
Source: reuters.com
The EU’s Carbon Border Adjustment Mechanism seeks to address carbon leakage and ensure fair competition…
Emerging market debt has surged since the pandemic, renewing concerns about rollover risk and fiscal…
Online platforms face a fundamental tension between removing toxic content and preserving the plurality of…
Efforts to reduce information asymmetries across firms are increasingly at the centre of Europe’s digital…
As geopolitical tensions from Ukraine to the Middle East disrupt global supply chains, understanding how…
China has become a serious contender at the frontier of pharmaceutical innovation. A key policy…